GSK and Astrazeneca shares slump as Trump vows drug price cut


 |  Updated: 

Astrazeneca and GSK have extensive activity in the US market.

Shares in London-listed drugmakers GSK and Astrazeneca tumbled on Monday morning after President Donald Trump said the US’ new pharma policy would make drug…

Source link